Revvity Inc. $RVTY Shares Sold by Federation des caisses Desjardins du Quebec

Key Points

• The Federation des caisses Desjardins du Quebec reduced its stake in Revvity Inc. by 3.5%, owning approximately $8.80 million worth of shares after selling 3,055 during the first quarter.
• Major institutional investors like T. Rowe Price and Vanguard Group have increased their holdings in Revvity, reflecting strong interest, as 86.65% of the stock is owned by such investors.
• Revvity's stock is currently down 5.3% and has a consensus rating of "Moderate Buy" with an average target price of $120.07 according to several analysts.

Federation des caisses Desjardins du Quebec lowered its stake in Revvity Inc. (NYSE:RVTY - Free Report) by 3.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,119 shares of the company's stock after selling 3,055 shares during the period. Federation des caisses Desjardins du Quebec owned approximately 0.07% of Revvity worth $8,799,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Mercer Global Advisors Inc. ADV grew its holdings in Revvity by 11.7% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,119 shares of the company's stock worth $1,687,000 after acquiring an additional 1,585 shares during the period. AXA S.A. grew its holdings in Revvity by 72.0% during the fourth quarter. AXA S.A. now owns 4,642 shares of the company's stock worth $518,000 after acquiring an additional 1,943 shares during the period. Ameriprise Financial Inc. grew its holdings in Revvity by 40.4% during the fourth quarter. Ameriprise Financial Inc. now owns 74,252 shares of the company's stock worth $8,287,000 after acquiring an additional 21,380 shares during the period. BNP Paribas Financial Markets grew its holdings in Revvity by 51.6% during the fourth quarter. BNP Paribas Financial Markets now owns 212,367 shares of the company's stock worth $23,702,000 after acquiring an additional 72,255 shares during the period. Finally, Cetera Investment Advisers boosted its position in Revvity by 17.2% during the fourth quarter. Cetera Investment Advisers now owns 5,786 shares of the company's stock worth $646,000 after purchasing an additional 848 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Trading Down 1.0%

NYSE:RVTY traded down $0.87 on Tuesday, hitting $85.41. 177,679 shares of the stock were exchanged, compared to its average volume of 1,180,858. The stock has a market cap of $9.91 billion, a PE ratio of 36.07, a PEG ratio of 2.33 and a beta of 0.94. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43. The stock has a fifty day moving average of $92.85 and a 200-day moving average of $96.80. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The company had revenue of $720.28 million during the quarter, compared to analyst estimates of $711.26 million. During the same period in the prior year, the firm posted $1.22 earnings per share. The firm's revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, equities analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be paid a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity's dividend payout ratio (DPR) is 11.86%.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Evercore ISI decreased their target price on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Bank of America decreased their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Stifel Nicolaus reduced their price objective on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Finally, Raymond James Financial restated an "outperform" rating and issued a $115.00 price objective (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Ten research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $120.07.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.